Polymyxin B-Enriched Exogenous Lung Surfactant: Thermodynamics and Structure
- 19 March 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 40 (13) , 6847-6861
Abstract
The use of an exogenous pulmonary surfactant (EPS) to deliver other relevant drugs to the lungs is a promising strategy for combined therapy. We evaluated the interaction of polymyxin B (PxB) with a clinically used EPS, the poractant alfa Curosurf (PSUR). The effect of PxB on the protein-free model system (MS) composed of four phospholipids (diC16:0PC/16:0-18:1PC/16:0-18:2PC/16:0-18:1PG) was examined in parallel to distinguish the specificity of the composition of PSUR. We used several experimental techniques (differential scanning calorimetry, small- and wide-angle X-ray scattering, small-angle neutron scattering, fluorescence spectroscopy, and electrophoretic light scattering) to characterize the binding of PxB to both EPS. Electrostatic interactions PxB-EPS are dominant. The results obtained support the concept of cationic PxB molecules lying on the surface of the PSUR bilayer, strengthening the multilamellar structure of PSUR as derived from SAXS and SANS. A protein-free MS mimics a natural EPS well but was found to be less resistant to penetration of PxB into the lipid bilayer. PxB does not affect the gel-to-fluid phase transition temperature, T-m, of PSUR, while T-m increased by similar to+ 2 degrees C in MS. The decrease of the thickness of the lipid bilayer (d(L)) of PSUR upon PxB binding is negligible. The hydrophobic tail of the PxB molecule does not penetrate the bilayer as derived from SANS data analysis and changes in lateral pressure monitored by excimer fluorescence at two depths of the hydrophobic region of the bilayer. Changes in d(L) of protein-free MS show a biphasic dependence on the adsorbed amount of PxB with a minimum close to the point of electroneutrality of the mixture. Our results do not discourage the concept of a combined treatment with PxB-enriched Curosurf. However, the amount of PxB must be carefully assessed (less than 5 wt % relative to the mass of the surfactant) to avoid inversion of the surface charge of the membrane.Keywords
All Related Versions
Funding Information
- Farmaceutick? fakulta, Univerzita Komensk?ho v Bratislave (FaF/27/2023, FaF/28/2023)
- Agent?ra Ministerstva ?kolstva, vedy, v?skumu a ?portu SR (VEGA 1/0223/20, VEGA 1/0305/24)
- Horizon 2020 Framework Programme (654000)
- Agent?ra na Podporu V?skumu a V?voja (APVV-17-0250)
This publication has 117 references indexed in Scilit:
- Structural hallmarks of lung surfactant: Lipid-protein interactions, membrane structure and future challengesArchives of Biochemistry and Biophysics, 2021
- Biophysical characterization of polymyxin b interaction with LPS aggregates and membrane model systemsPeptide Science, 2012
- Small-Angle Scattering from Homogenous and Heterogeneous Lipid Bilayers2010
- Cut-off effects in biological activities of surfactantsAdvances in Colloid and Interface Science, 1996
- Small-volume extrusion apparatus for preparation of large, unilamellar vesiclesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Structure Analysis by Small-Angle X-Ray and Neutron Scattering1987
- Lipid polymorphism and the roles of lipids in membranesChemistry and Physics of Lipids, 1986
- X-ray analysis and calorimetry on phosphatidylcholine model membranes. The influence of length and position of acyl chains upon structure and phase behaviourBiochimica et Biophysica Acta (BBA) - Biomembranes, 1983
- Preferred conformation and molecular packing of phosphatidylethanolamine and phosphatidylcholineBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1981
- Excimer fluorescence spectra of pyrene derivativesSpectrochimica Acta, 1963